275 related articles for article (PubMed ID: 33258450)
1. An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen.
Morley VJ; Kinnear CL; Sim DG; Olson SN; Jackson LM; Hansen E; Usher GA; Showalter SA; Pai MP; Woods RJ; Read AF
Elife; 2020 Dec; 9():. PubMed ID: 33258450
[TBL] [Abstract][Full Text] [Related]
2. An orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy.
Morley VJ; Sim DG; Penkevich A; Woods RJ; Read AF
Evol Med Public Health; 2022; 10(1):439-446. PubMed ID: 36118914
[TBL] [Abstract][Full Text] [Related]
3. Ion Exchange Biomaterials to Capture Daptomycin and Prevent Resistance Evolution in Off-Target Bacterial Populations.
Yeh SL; Narasimhalu N; Vom Steeg LG; Muthami J; LeConey S; He Z; Pitcher M; Cassady H; Morley VJ; Cho SH; Bator C; Koshani R; Woods RJ; Hickner M; Read AF; Sheikhi A
ACS Appl Mater Interfaces; 2022 Sep; 14(38):42864-42875. PubMed ID: 36103577
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
[TBL] [Abstract][Full Text] [Related]
5. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
[TBL] [Abstract][Full Text] [Related]
6. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
Shukla BS; Shelburne S; Reyes K; Kamboj M; Lewis JD; Rincon SL; Reyes J; Carvajal LP; Panesso D; Sifri CD; Zervos MJ; Pamer EG; Tran TT; Adachi J; Munita JM; Hasbun R; Arias CA
Clin Infect Dis; 2016 Jun; 62(12):1514-1520. PubMed ID: 27045126
[TBL] [Abstract][Full Text] [Related]
7. Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.
Kinnear CL; Patel TS; Young CL; Marshall V; Newton DW; Read AF; Woods RJ
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718245
[TBL] [Abstract][Full Text] [Related]
8. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
[No Abstract] [Full Text] [Related]
9. Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium.
Kinnear CL; Hansen E; Morley VJ; Tracy KC; Forstchen M; Read AF; Woods RJ
PLoS Biol; 2020 Dec; 18(12):e3000987. PubMed ID: 33332354
[TBL] [Abstract][Full Text] [Related]
10. Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
Menon V; Davis R; Shackel N; Espedido BA; Beukers AG; Jensen SO; van Hal SJ
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):120-122. PubMed ID: 29195768
[TBL] [Abstract][Full Text] [Related]
11. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
[TBL] [Abstract][Full Text] [Related]
12. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
Caballero S; Carter R; Ke X; Sušac B; Leiner IM; Kim GJ; Miller L; Ling L; Manova K; Pamer EG
PLoS Pathog; 2015 Sep; 11(9):e1005132. PubMed ID: 26334306
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin for highly resistant Enterococcus faecium infection.
Rosin C; Bernsmeier C; Entenza JM; Moreillon P; Frei R; Weisser M; Flückiger U
Swiss Med Wkly; 2012; 142():w13603. PubMed ID: 22736040
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.
DiPippo AJ; Tverdek FP; Tarrand JJ; Munita JM; Tran TT; Arias CA; Shelburne SA; Aitken SL
J Infect; 2017 Mar; 74(3):243-247. PubMed ID: 27845153
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of resistance to daptomycin in Enterococcus faecium.
Montero CI; Stock F; Murray PR
Antimicrob Agents Chemother; 2008 Mar; 52(3):1167-70. PubMed ID: 18180351
[TBL] [Abstract][Full Text] [Related]
16. Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.
Kelesidis T; Tewhey R; Humphries RM
J Antimicrob Chemother; 2013 Aug; 68(8):1926-8. PubMed ID: 23580562
[No Abstract] [Full Text] [Related]
17. LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in
Axell-House DB; Simar SR; Panesso D; Rincon S; Miller WR; Khan A; Pemberton OA; Valdez L; Nguyen AH; Hood KS; Rydell K; DeTranaltes AM; Jones MN; Atterstrom R; Reyes J; Sahasrabhojane PV; Suleyman G; Zervos M; Shelburne SA; Singh KV; Shamoo Y; Hanson BM; Tran TT; Arias CA
Antimicrob Agents Chemother; 2024 Mar; 68(3):e0106923. PubMed ID: 38289081
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin in bone and joint infections: a review of the literature.
Rice DA; Mendez-Vigo L
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
[TBL] [Abstract][Full Text] [Related]
19. Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance.
Sinel C; Augagneur Y; Sassi M; Bronsard J; Cacaci M; Guérin F; Sanguinetti M; Meignen P; Cattoir V; Felden B
Sci Rep; 2017 Sep; 7(1):11067. PubMed ID: 28894187
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
